Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 324 questions Show Answers
Submitting member has a registered interest.
To ask the Scottish Government what the current arrangements are to allow pharmacists working in the community to access their patients’ clinical records; which records they can see, and whether they can amend records to include consultations and items prescribed by the pharmacist.
Submitting member has a registered interest.
To ask the Scottish Government what steps are being taken to review the current reported restrictions on pharmacists working in the community having access to full clinical records for patients in their care to ensure safe prescribing.
Submitting member has a registered interest.
To ask the Scottish Government what its policy goals are for pharmacists working in the community in relation to being able to access full clinical records for patients in their care to ensure safe prescribing, and when it expects these goals to be met.
Submitting member has a registered interest.
To ask the Scottish Government for what reason pharmacists working in communities reportedly do not have full access to clinical records for people in their care.
Submitting member has a registered interest.
To ask the Scottish Government what assessment it has made of the impact of the delay in implementing the Fracture Liaison Service audit on the ability to (a) evaluate gaps in osteoporosis care and (b) prevent avoidable fractures.
To ask the Scottish Government what its response is to reports of some teachers requesting self-defence classes due to the prevalence of violence in schools.
Submitting member has a registered interest.
To ask the Scottish Government how many people in Scotland have (a) transfusion dependent thalassaemia and (b) sickle cell disease, also broken down by how many might be eligible for treatment with exagamglogene autotemcel, a gene-edited therapy manufactured in Scotland, if this was made available.
Submitting member has a registered interest.
To ask the Scottish Government, following the treatment, exagamglogene autotemcel, which is a gene-edited therapy manufactured in Scotland, being approved for use in England to treat (a) transfusion dependent thalassaemia and (b) sickle cell disease, what engagement it is having with the NHS and suppliers toward making this available in Scotland, also broken down by what date it will be made available to people eligible for it, if approved.
To ask the Scottish Government whether it will provide an update on the progress with the cladding remediation programme.
To ask the Scottish Government what it is doing to support and grow the night-time economy in Glasgow.